# Regional Anesthesia in Total Hip and Knee Arthroplasty

> **NCT04257682** · PHASE4 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 135 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Hip Osteoarthritis

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Ropivacaine
- **DRUG:** Mepivacaine

## Key facts

- **NCT ID:** NCT04257682
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2023-02
- **Final completion:** 2023-02
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04257682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04257682, "Regional Anesthesia in Total Hip and Knee Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04257682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
